Orexo AB (publ) (STO:ORX)
22.40
+0.60 (2.75%)
Mar 25, 2026, 3:19 PM CET
Orexo AB Employees
Orexo AB had 72 employees as of December 31, 2025. The number of employees decreased by 38 or -34.55% compared to the previous year.
Employees
72
Change
-38
Growth
-34.55%
Revenue / Employee
361.11K SEK
Profits / Employee
8.88M SEK
Market Cap
765.77M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 72 | -38 | -34.55% |
| Sep 30, 2025 | 104 | -9 | -7.96% |
| Jun 30, 2025 | 110 | -2 | -1.79% |
| Mar 31, 2025 | 110 | -3 | -2.65% |
| Dec 31, 2024 | 110 | -6 | -5.17% |
| Sep 30, 2024 | 113 | -5 | -4.24% |
| Jun 30, 2024 | 112 | -8 | -6.67% |
| Mar 31, 2024 | 113 | -9 | -7.38% |
| Dec 31, 2023 | 116 | -10 | -7.94% |
| Sep 30, 2023 | 118 | -8 | -6.35% |
| Jun 30, 2023 | 120 | -3 | -2.44% |
| Mar 31, 2023 | 122 | -1 | -0.81% |
| Dec 31, 2022 | 126 | 7 | 5.88% |
| Sep 30, 2022 | 126 | -2 | -1.56% |
| Jun 30, 2022 | 123 | -16 | -11.51% |
| Mar 31, 2022 | 123 | -22 | -15.17% |
| Dec 31, 2021 | 119 | -18 | -13.14% |
| Sep 30, 2021 | 128 | -8 | -5.88% |
| Jun 30, 2021 | 139 | 3 | 2.21% |
| Mar 31, 2021 | 145 | 13 | 9.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioGaia AB | 242 |
| EQL Pharma AB | 55 |
| Cinclus Pharma Holding AB | 21 |
| Enzymatica AB | 20 |
| Nanexa AB | 15 |
| Cereno Scientific AB | 10 |
| Moberg Pharma AB | 5 |
| Enorama Pharma AB | 5 |
Orexo AB News
- 18 days ago - Invitation & Agenda: Orexo R&D Day on March 24 - PRNewsWire
- 18 days ago - Orexo changes the organizational structure and management team to increase focus on development of new products - PRNewsWire
- 6 weeks ago - Orexo AB (publ) (ORXOY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Orexo AB (publ) (ORXOY) Discusses Divestment of US Rights to Zubsolv and Transition Agreement with Dexcel Pharma Transcript - Seeking Alpha
- 5 months ago - Orexo AB (publ) (ORXOY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 7 months ago - Orexo's AmorphOX technology may pave the way for intranasal GLP-1 medication - PRNewsWire
- 10 months ago - Orexo to present clinical data for OX640 at the EAACI Congress - PRNewsWire
- 1 year ago - Orexo announces positive data for powder-based intranasal vaccine formulated with the AmorphOX technology - PRNewsWire